Fierce Biotech February 23, 2024
Andrea Park

The FDA issued a safety communication this week warning Americans that if they see a smartwatch or smart ring claiming to offer noninvasive blood sugar monitoring, the agency had nothing to do with it, thank you very much.

Though quite a few technology developers—of both the medtech and broader Big Tech varieties—are currently working toward building portable devices that can accurately measure glucose levels without having to pierce the skin, none have yet to pass the FDA’s muster.

The regulator didn’t call out any specific peddlers of the unauthorized devices in its notice, but said they’re “manufactured by dozens of companies and sold under multiple brand names.”

The notice warned that since the devices’ safety and efficacy haven’t been reviewed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Medical Devices, Technology, Wearables
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
11 drugs now in shortage
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Pfizer hemophilia gene therapy arrives in US to uncertain future
Pfizer’s First Gene Therapy Approval Sets Up a Showdown With CSL in Hemophilia B

Share This Article